Association of HSP90B1 genetic polymorphisms with efficacy of glucocorticoids and improvement of HRQoL in systemic lupus erythematosus patients from Anhui Province.
暂无分享,去创建一个
Qiang Zhou | D. Ye | Jian-hua Xu | Qiaomei Xie | Man Zhang | Y. Zou | Shengqian Xu | F. Pan | H. Pan | H. Su | De-guang Wang | Jin-Hui Tao | Yuan-yuan Gu | Hui Xiao | Peiling Chen | Shuang Liu | Jing Cai | L. Lian | Shengxiu Liu | Chun-mei Liang | Xiu-Xiu Sun | Su-Su Li | L. Qian | Chun-Huai Wang | Youfa Fang | Hailiang Huang | Shengqian Xu | Shengqian Xu
[1] H. Yamanaka,et al. Reliability of the SF-36 in Japanese patients with systemic lupus erythematosus and its associations with disease activity and damage: a two-consecutive year prospective study , 2018, Lupus.
[2] D. Ye,et al. Single nucleotide polymorphisms of HSP90AA1 gene influence response of SLE patients to glucocorticoids treatment , 2016, SpringerPlus.
[3] T. Shimoda,et al. Quality of life in Japanese female patients with systemic lupus erythematosus: Evaluation using the Short Form 36 Health Survey , 2016, Modern rheumatology.
[4] D. Isenberg,et al. What can we learn from systemic lupus erythematosus pathophysiology to improve current therapy? , 2015, Expert review of clinical immunology.
[5] D. Ye,et al. Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus , 2015, Clinical Rheumatology.
[6] L. Punzi,et al. Optimizing outcome in SLE: treating-to-target and definition of treatment goals. , 2014, Autoimmunity reviews.
[7] J. Aviña-Zubieta,et al. Overall and Cause‐Specific Mortality in Patients With Systemic Lupus Erythematosus: A Meta‐Analysis of Observational Studies , 2014, Arthritis care & research.
[8] A. Takaki,et al. Assessment of health‐related quality of life and how it predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C , 2014, Journal of gastroenterology and hepatology.
[9] C. Gyawali,et al. Genetic variation in the beta‐2 adrenergic receptor (ADRB2) predicts functional gastrointestinal diagnoses and poorer health‐related quality of life , 2013, Alimentary pharmacology & therapeutics.
[10] D. Cabanes,et al. Listeria monocytogenes Triggers the Cell Surface Expression of Gp96 Protein and Interacts with Its N Terminus to Support Cellular Infection* , 2012, The Journal of Biological Chemistry.
[11] D. Hwang,et al. A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis , 2012, The Journal of experimental medicine.
[12] Y. Argon,et al. GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum. , 2012, Biochimica et biophysica acta.
[13] K. Nagata,et al. ER Stress Proteins in Autoimmune and Inflammatory Diseases , 2012, Front. Immun..
[14] R. Binder,et al. CD91-dependent programming of T-helper cell responses following heat shock protein immunization. , 2011, Nature communications.
[15] Shigeaki Suzuki,et al. Autoimmunity to endoplasmic reticulum chaperone GRP94 in myasthenia gravis , 2011, Journal of Neuroimmunology.
[16] Sunghoon Kim,et al. Identification of gp96 as a Novel Target for Treatment of Autoimmune Disease in Mice , 2010, PloS one.
[17] Y. Shoenfeld,et al. The geoepidemiology of systemic lupus erythematosus. , 2010, Autoimmunity reviews.
[18] Ying Wang,et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus , 2009, Nature Genetics.
[19] P. Tak,et al. Heat Shock Protein 96 Is Elevated in Rheumatoid Arthritis and Activates Macrophages Primarily via TLR2 Signaling 1 , 2009, The Journal of Immunology.
[20] V. Strand,et al. Health-related quality of life in patients with systemic lupus erythematosus: an update. , 2007, Annals of the Academy of Medicine, Singapore.
[21] R. Kaufman,et al. The unfolded protein response , 2006, Neurology.
[22] Zihai Li,et al. Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[23] Y. Nasuhara,et al. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. , 1996, British journal of pharmacology.
[24] J E Ware,et al. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. , 1998, Journal of clinical epidemiology.
[25] R. Morimoto,et al. Stress–inducible responses and heat shock proteins: New pharmacologic targets for cytoprotection , 1998, Nature Biotechnology.
[26] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[27] W. Pratt,et al. The Cyclosporin A-binding Immunophilin CyP-40 and the FK506-binding Immunophilin hsp56 Bind to a Common Site on hsp90 and Exist in Independent Cytosolic Heterocomplexes with the Untransformed Glucocorticoid Receptor (*) , 1995, The Journal of Biological Chemistry.
[28] C. Malchoff,et al. Glucocorticoid Resistance , 2020, Definitions.
[29] H. Söling,et al. Systemic lupus erythematosus is associated with increased auto‐antibody titers against calreticulin and Grp94, but calreticulin is not the Ro/SS‐A antigen , 1994, European journal of clinical investigation.
[30] S. Detera-Wadleigh,et al. The genomic structure of the human glucocorticoid receptor. , 1991, The Journal of biological chemistry.